Audrey Warner

Audrey is Co-Founder and Managing Partner at 28 Capital, formerly known as Tiger Gene, a venture capital fund that forms companies and invests in early-stage platform technologies with high-growth trajectories across the life sciences sector. She currently serves as Chief Business Officer and Board Observer at BrickBio, Inc., Board Director of NanoMosaic Inc., Board Director of Valora Therapeutics, Inc, Board Director of EnCapsid Therapeutics, and Board Observer of Precede Biosciences. Audrey also serves on the Team USA Next-Gen Advisory Board (USOPC) and on the Advisory Board of the Harvard Varsity Club. She holds a degree from Harvard College and was a member of the Varsity Women's Ice Hockey Team.